This article is more than 5 years old. Information may no longer be current.

STAAR Surgical net sales decline in first quarter; ICL sales increase

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

MONROVIA, Calif. — STAAR Surgical reported net sales of $13.3 million during the first quarter of 2006, a 3% decline from the year-ago period, the company said in a press release. ICL sales increased 73% during the quarter compared to the year-ago period, and accounted for 18% of the company’s overall sales during the quarter, the release said

Preloaded silicone IOL sales increased 29% from the first quarter of 2005, the release said.

U.S. net sales for the quarter increased 4% to $5.1 million, and “primarily reflects the launch of the Visian ICL in the first quarter of 2006,” the company said. First quarter 2006 cataract product sales declined 13% in the United States compared to the year-ago quarter, STAAR said.

“The slight, overall decline in year-over-year international sales during the first quarter was mostly attributable to difficult cataract market conditions in Germany,” said David Bailey, president and chief executive officer.